Top players in CRAMs
India has made a significant transition from pharmaceutical production to contract manufacturing during the last few decades. According to the Indian Drug Manufacturers' Association, the pharmaceutical CMO sector offers a sizable opportunity for small and medium-sized businesses. The CAGR for the Indian CMO market is predicted to be 13.3% from 2021 to 2026. The Indian pharmaceutical contract manufacturing market would have an increasing trend due to the increase in demand for injectable medications, particularly in cancer research. Compared to other drug formulation types, injectable medications give larger returns. The country's injectable formulation market is thus anticipated to increase as a result of higher ROI and therapeutic efficacy. India has an advantage over countries like Vietnam, China, and Ireland when it comes to basic medical product manufacturing because to resources like labour, a technically skilled workforce, and production facilities that have received ...